Laustsen, Andreas H.
María Gutiérrez, José
Knudsen, Cecilie
Johansen, Kristoffer H.
Bermúdez-Méndez, Erick
Cerni, Felipe A.
Jürgensen, Jonas A.
Ledsgaard, Line
Martos-Esteban, Andrea
Øhlenschlæger, Mia
Pus, Urska
Andersen, Mikael R.
Lomonte, Bruno https://orcid.org/0000-0003-2419-6469
Engmark, Mikael
Pucca, Manuela B.
Funding for this research was provided by:
Conselho Nacional de Desenvolvimento Científico e Tecnológico (150749/2017-1)
Universidad de Costa Rica (OAICE-CAB-05-56-2016)
Ministerio de Ciencia Tecnología y Telecomunicaciones (PEM-066-2015-II)
Novo Nordisk Fonden (NNF13OC0005613)
Novo Nordisk Fonden (NNF16OC0019248)
This article is maintained by: Elsevier
Article Title: Pros and cons of different therapeutic antibody formats for recombinant antivenom development
Journal Title: Toxicon
CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.toxicon.2018.03.004
Content Type: article
Copyright: © 2018 The Authors. Published by Elsevier Ltd.